Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 4
1991 3
1992 1
1993 1
1994 1
1995 2
1996 4
1997 1
1998 2
1999 1
2000 1
2003 3
2004 4
2005 4
2006 2
2007 5
2008 6
2009 3
2010 8
2011 9
2012 9
2013 10
2014 13
2015 10
2016 8
2017 9
2018 17
2019 13
2020 17
2021 11
2022 4
2023 5
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric pharmacology.
Kaguelidou F, Kassai Koupai B, Durrieu G. Kaguelidou F, et al. Among authors: durrieu g. Therapie. 2018 Apr;73(2):111-112. doi: 10.1016/j.therap.2018.02.003. Epub 2018 Feb 21. Therapie. 2018. PMID: 29602602 No abstract available.
Pharmacovigilance in pediatrics.
Bouquet É, Star K, Jonville-Béra AP, Durrieu G. Bouquet É, et al. Among authors: durrieu g. Therapie. 2018 Apr;73(2):171-180. doi: 10.1016/j.therap.2017.11.012. Epub 2018 Feb 16. Therapie. 2018. PMID: 29598957
Atropinic (Anticholinergic) Burden in Parkinson's Disease.
De Germay S, Montastruc JL, Rousseau V, Chebane L, Bondon-Guitton E, Moulis F, Durrieu G, Bagheri H, Rascol O, Pariente A, Bégaud B, Montastruc F. De Germay S, et al. Among authors: durrieu g. Mov Disord. 2016 May;31(5):632-6. doi: 10.1002/mds.26595. Epub 2016 Mar 29. Mov Disord. 2016. PMID: 27028036 Review.
Pharmacovigilance, risks and adverse effects of self-medication.
Montastruc JL, Bondon-Guitton E, Abadie D, Lacroix I, Berreni A, Pugnet G, Durrieu G, Sailler L, Giroud JP, Damase-Michel C, Montastruc F. Montastruc JL, et al. Among authors: durrieu g. Therapie. 2016 Apr;71(2):257-62. doi: 10.1016/j.therap.2016.02.012. Epub 2016 Feb 6. Therapie. 2016. PMID: 27080848 Review. English, French.
Amiodarone and Parkinsonism: a pharmacovigilance study.
Montastruc JL, Durrieu G. Montastruc JL, et al. Among authors: durrieu g. Fundam Clin Pharmacol. 2021 Aug;35(4):781-784. doi: 10.1111/fcp.12618. Epub 2020 Nov 9. Fundam Clin Pharmacol. 2021. PMID: 33098706
Off-label and unlicensed drug use in children population.
Moulis F, Durrieu G, Lapeyre-Mestre M. Moulis F, et al. Among authors: durrieu g. Therapie. 2018 Apr;73(2):135-149. doi: 10.1016/j.therap.2018.02.002. Epub 2018 Feb 16. Therapie. 2018. PMID: 29580614 Review.
Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis.
Teboul A, Chouchana L, Durrieu G, Eftekhari P, Treluyer JM, Mouthon L, Chaigne B. Teboul A, et al. Among authors: durrieu g. J Am Acad Dermatol. 2022 Jun;86(6):1372-1375. doi: 10.1016/j.jaad.2021.05.030. Epub 2021 May 27. J Am Acad Dermatol. 2022. PMID: 34052335 No abstract available.
159 results